NS5-targeting nucleoside analogs inhibit dengue virus and other flaviviruses
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1013970 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Priyanka Bhakt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Dengue Virus, Antiviral Agents, Viral Nonstructural Proteins, Nucleosides. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH, CAMPP Antiviral Drug Discovery (AViDD) Center, Burroughs Wellcome Investigators.
Abstract (Originalsprache)
Dengue virus (DENV) is a mosquito-transmitted flavivirus that circulates globally as four distinct serotypes and poses a substantial threat to public health. There are an estimated ~96 million symptomatic infections yearly, including severe cases of dengue fever, underscoring the urgency of identifying effective therapeutics targeting all four serotypes. Nucleoside analogs, which mimic endogenous nucleosides to inhibit viral RNA replication, offer a promising strategy for broad-spectrum antiviral development. Here, we conducted a high-throughput screen of 1,101 nucleoside analogs against DENV serotype 2 (DENV2) in a panel of human cell models, including human epithelial cells, hepatocytes, and fibroblasts. Candidates that were active against DENV2 were screened against all four serotypes. Since flaviviruses including West Nile virus and Zika virus are also important human pathogens, we screened these compounds for activity and identified compounds that were broadly active in these cellular and viral models. We further evaluated antivirals in primary human keratinocytes and fibroblasts, which are early targets of mosquito-transmitted DENV infection. From this screen, we identified 23 nucleoside analogs with broad antiviral activity against DENV and focused on two purine analogs UPGNUC255 and UPGNUC558, that demonstrated potent pan-flaviviral activity achieving >10-fold viral load reduction across all four DENV serotypes and other flaviviruses across cell models. Mechanistic studies revealed that both compounds target the viral RNA-dependent RNA polymerase (RdRp) domain of NS5. Resistance to UPGNUC558 was associated with a conserved S604T substitution, conferring cross-resistance to other 2′C-substituted nucleoside analogs. Resistance to UPGNUC255 was linked to a previously unknown R355Q mutation, located near the catalytic GDD motif of RdRp. These findings highlight UPGNUC255 and UPGNUC558 as promising leads for the development of broad-spectrum antiviral agents against flaviviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Department of Biochemistry and Biophysics, High throughput screening core, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
- Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
- Calibr-Skaggs at Scripps Research Institute, La Jolla, California, United States of America.
ORCID-Profile: Sara Cherry
Förderung
- NIH
- CAMPP Antiviral Drug Discovery (AViDD) Center
- Burroughs Wellcome Investigators
Zitieren
APA
Bhakt, P., Pokharel, S. M., Li, Y., Srivastava, T., Miller, J., Dittmar, M., Zhu, Y., Nguyen, D., Walter, Z., Ayyanathan, K., Tudor, M., Yu, C., Chatterjee, A. K., Ramage, H., Schultz, D., & Cherry, S. (2026). NS5-targeting nucleoside analogs inhibit dengue virus and other flaviviruses. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013970
Vancouver
Bhakt P, Pokharel SM, Li Y, Srivastava T, Miller J, Dittmar M, et al. NS5-targeting nucleoside analogs inhibit dengue virus and other flaviviruses. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013970
BibTeX
@article{Bhakt2026,
author = {Bhakt, Priyanka and Pokharel, Swechha M and Li, Yue and Srivastava, Tamanna and Miller, Jesse and Dittmar, Mark and Zhu, Yongqing and Nguyen, David and Walter, Zachary and Ayyanathan, Kasirajan and Tudor, Matthew and Yu, Chenguang and Chatterjee, Arnab K and Ramage, Holly and Schultz, David and Cherry, Sara},
title = {NS5-targeting nucleoside analogs inhibit dengue virus and other flaviviruses},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1013970}
}
EUVIMED